The Kerala High Court has held that the government is empowered under Section 100 of the Patents Act to produce and sell patented cancer drugs at non-commercial rates to ensure affordable healthcare. The ruling links the right to life (Article 21) and the state's duty to improve public health (Article 47), making it a landmark judgment for access to essential medicines.
Exam Lens
Quick Exam Facts From News
1-Minute Revision
- ›Court: Kerala High Court
- ›Judge: Justice Harisankar V Menon
- ›Target this Data: ₹58,140 for 21 days of Ribociclib; monthly pension ₹28,400
- ›Target this Legal Point: Section 100 of the Patents Act, 1970
- ›Target this Constitutional Link: Article 21 (right to life) and Article 47 (duty to improve public health)
Mastered this topic? Test your knowledge with a full MCQ quiz.
Practice exam-style questions, track your score, and strengthen your recall.